{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:55:01Z","timestamp":1767855301776,"version":"3.49.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>A 35-year-old man with painful and difficult urination underwent <jats:sup>18<\/jats:sup>F-FDG and Al<jats:sup>18<\/jats:sup>F-Thretide PET\/CT scans after a pelvic MRI suggested a prostate mass. The <jats:sup>18<\/jats:sup>F-FDG and Al<jats:sup>18<\/jats:sup>F-Thretide PET\/CT scans revealed a prostate mass accompanied by an intravenous tumor thrombus. Both the prostate mass and the intravenous tumor thrombus demonstrated increased FDG uptake. Intense PSMA activity was observed in both lesions, with the intravenous tumor thrombus showing considerably higher PSMA activity compared with its FDG uptake. Histologic analysis of the biopsy confirmed the diagnosis of prostatic synovial sarcoma. PSMA immunohistochemistry showed high PSMA expression in the vascular endothelial cells within the tumor.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005886","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T01:00:10Z","timestamp":1747789210000},"page":"887-888","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Primary Prostatic Synovial Sarcoma With Intravenous Tumor Thrombus Presented on 18F-FDG and Al18F-Thretide PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8619-4878","authenticated-orcid":false,"given":"Xin","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine (PET-CT Center), National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Beijing Key Laboratory of Urologic Cancer Cell and Gene Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guozhu","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine (PET-CT Center), National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Urologic Cancer Cell and Gene Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Pathology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Urologic Cancer Cell and Gene Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Urology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine (PET-CT Center), National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"101618","DOI":"10.1016\/j.esmoop.2023.101618","article-title":"Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies","volume":"8","author":"Blay","year":"2023","journal-title":"ESMO Open"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5858\/arpa.2016-0101-RS","article-title":"Primary intraprostatic synovial sarcoma","volume":"141","author":"Olofson","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.123.266940","article-title":"Diagnostic performance of [18F]AlF-Thretide PET\/CT in patients with newly diagnosed prostate cancer using histopathology as reference standard","volume":"65","author":"Zang","year":"2024","journal-title":"J Nucl Med"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00259-024-06859-8","article-title":"Internal auditory canal tumor presented on [18F]AlF-FAPI-74 and [18F]AlF-PSMA-BCH PET\/CT in a prostate cancer patient","volume":"52","author":"Cheng","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00259-022-06101-3","article-title":"Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET\/CT in patients with clear cell renal cell carcinoma: a pilot study","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/RLU.0000000000003336","article-title":"Recurrent brain metastasis of triple negative breast cancer with high uptake in 68Ga-PSMA-11 PET\/CT","volume":"46","author":"Arslan","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1097\/RLU.0000000000005446","article-title":"68Ga-prostate-specific membrane antigen PET\/CT in endometrial cancer: a preliminary report","volume":"49","author":"Kunikowska","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/RLU.0000000000002716","article-title":"68Ga-prostate-specific membrane antigen-11 PET\/CT: incidental finding of a vestibular schwannoma","volume":"44","author":"Al\u00e7in","year":"2019","journal-title":"Clin Nucl Med"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1097\/RLU.0000000000005361","article-title":"Incidental 68 Ga-PSMA uptake in the benign enchondroma\u2014a rare finding on 68 Ga-PSMA PET\/CT","volume":"49","author":"Singh","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R10-20250731","first-page":"e43","article-title":"A case report: PSMA PET\/CT in retroperitoneal hemangioma","volume":"50","author":"Al Sawafi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/RLU.0000000000005389","article-title":"Primary prostatic stromal sarcoma on 18 F-PSMA PET\/CT","volume":"49","author":"Chen","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/RLU.0000000000002189","article-title":"Incidental detection of tracer avidity in liposarcoma on 68Ga-labeled prostate-specific membrane antigen PET\/CT","volume":"43","author":"Malik","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1097\/RLU.0000000000003780","article-title":"Prostate-specific membrane antigen expression in metastatic angiosarcoma detected on 18F-PMSA PET\/CT: a new potential prognostic marker","volume":"47","author":"Marafi","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/RLU.0000000000004725","article-title":"Rapid tumor washout of 177 Lu-PSMA radioligand in renal cell carcinoma","volume":"48","author":"Zhang","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T05:00:35Z","timestamp":1753938035000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005886","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"2024-12-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}